Total Payments
$4,953
2023 Payments
$46.34
Companies
22
Transactions
239
Medicare Patients
775
Medicare Billing
$79,226
Payment Breakdown by Category
Food & Beverage$4,635 (93.6%)
Travel$313.69 (6.3%)
Education$4.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,635 | 236 | 93.6% |
| Travel and Lodging | $313.69 | 2 | 6.3% |
| Education | $4.20 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $2,331 | 133 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $612.20 | 3 | $0 (2018) |
| Gilead Sciences, Inc. | $361.76 | 5 | $0 (2020) |
| PFIZER INC. | $250.85 | 31 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $216.92 | 7 | $0 (2021) |
| Nestle HealthCare Nutrition Inc. | $190.46 | 12 | $0 (2022) |
| Synergy Pharmaceuticals Inc | $174.99 | 6 | $0 (2018) |
| Intuitive Surgical, Inc. | $110.37 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $105.17 | 7 | $0 (2022) |
| Janssen Biotech, Inc. | $104.51 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $46.34 | 2 | AbbVie Inc. ($46.34) |
| 2022 | $1,088 | 72 | ABBVIE INC. ($675.95) |
| 2021 | $1,079 | 58 | AbbVie Inc. ($643.54) |
| 2020 | $548.81 | 37 | AbbVie Inc. ($316.07) |
| 2019 | $271.07 | 20 | AbbVie, Inc. ($206.07) |
| 2018 | $1,301 | 35 | Ironwood Pharmaceuticals, Inc ($612.20) |
| 2017 | $618.19 | 15 | AbbVie, Inc. ($262.46) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: IMMUNOLOGY | ||||||
| 01/27/2023 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/20/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/08/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/16/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/10/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/08/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Antibiotic | ||||||
| 09/29/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Immunology | ||||||
| 09/28/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/28/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/16/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/13/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $79.88 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 277 | 290 | $177,150 | $28,198 |
| 2021 | 8 | 267 | 282 | $156,364 | $29,534 |
| 2020 | 8 | 231 | 240 | $122,813 | $21,494 |
Total Patients
775
Total Services
812
Medicare Billing
$79,226
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 82 | 85 | $21,250 | $8,881 | 41.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 61 | 61 | $50,752 | $8,209 | 16.2% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 27 | 29 | $19,198 | $4,313 | 22.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 80 | $52,000 | $4,086 | 7.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 31 | 35 | $33,950 | $2,710 | 8.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 59 | 59 | $49,088 | $8,569 | 17.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 70 | 72 | $18,000 | $7,669 | 42.6% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 22 | 23 | $15,226 | $3,401 | 22.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 43 | 47 | $30,550 | $3,301 | 10.8% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 33 | 33 | $28,400 | $2,410 | 8.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 11 | 11 | $9,185 | $2,143 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 21 | $3,675 | $1,429 | 38.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 16 | $2,240 | $612.50 | 27.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 47 | 47 | $39,104 | $6,203 | 15.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 48 | 49 | $12,250 | $5,422 | 44.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 52 | 54 | $35,100 | $2,712 | 7.7% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 16 | 17 | $11,254 | $2,520 | 22.4% |
| 43249 | Balloon dilation of esophagus using an endoscope | Facility | 2020 | 23 | 24 | $16,800 | $2,323 | 13.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 19 | $3,325 | $902.70 | 27.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 13 | $2,600 | $855.32 | 32.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 17 | $2,380 | $556.02 | 23.4% |
About Dr. Kent Smith, M.D
Dr. Kent Smith, M.D is a Gastroenterology healthcare provider based in Riverton, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336183813.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Smith, M.D has received a total of $4,953 in payments from pharmaceutical and medical device companies, with $46.34 received in 2023. These payments were reported across 239 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,635).
As a Medicare-enrolled provider, Smith has provided services to 775 Medicare beneficiaries, totaling 812 services with total Medicare billing of $79,226. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Riverton, UT
- Active Since 06/15/2006
- Last Updated 11/13/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1336183813
Products in Payments
- CREON (Drug) $494.48
- HUMIRA (Biological) $417.93
- LINZESS (Drug) $260.57
- Humira (Biological) $243.16
- Vemlidy (Drug) $223.89
- XELJANZ (Drug) $206.28
- Mavyret (Drug) $194.23
- Viekira (Drug) $194.21
- ZENPEP (Drug) $190.46
- RINVOQ (Biological) $182.48
- Trulance (Drug) $174.99
- SKYRIZI (Biological) $142.24
- MAVYRET (Drug) $115.94
- Entyvio (Biological) $112.68
- Da Vinci Surgical System (Device) $110.37
- Epclusa (Drug) $102.14
- STELARA (Biological) $98.60
- XIFAXAN (Drug) $88.99
- SUCRAID (Drug) $82.60
- ENTYVIO (Biological) $68.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.